SCHEMBL855955

SCHEMBL855955

COc1cc(C(N)=O)ccc1OCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.62
MAPK1 P28482 1/20 0.59
MRGPRX4 Q96LA9 3/20 0.55
MAPT P10636 3/20 0.54
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 1/20 0.54
RXRA P19793 2/20 0.54
RXRB P28702 1/20 0.54
RXRG P48443 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
NPC1 O15118 1/20 0.52
HPGD P15428 1/20 0.52
RAB9A P51151 1/20 0.52
SMPD1 P17405 1/20 0.50
ATM Q13315 1/20 0.50
HDAC1 Q13547 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20463436 0.89 MAOB (0.64) MAOBMRGPRX4MAPTKDM4EALDH1A1
SCHEMBL20456188 0.89 MRGPRX4 (0.70) MAOBMRGPRX4MAPTRXRARXRB
SCHEMBL22386763 0.88 MRGPRX4 (0.58) MAOBMRGPRX4MAPTKDM4EALDH1A1
SCHEMBL20463488 0.88 MRGPRX4 (0.58) MAOBMRGPRX4MAPTKDM4EALDH1A1
SCHEMBL22386778 0.86 MRGPRX4 (0.54) MAOBMRGPRX4MAPTKDM4EALDH1A1
SCHEMBL22386726 0.85 MRGPRX4 (0.53) MAOBMRGPRX4MAPTKDM4EALDH1A1
SCHEMBL12112529 0.85 SMN1; SMN2 (0.57) MAOBMRGPRX4MAPTKDM4EALDH1A1
SCHEMBL856030 0.85 RXRA (0.70) MAOBMRGPRX4RXRARXRBRXRG
SCHEMBL20456200 0.84 SMN1; SMN2 (0.56) MAOBMRGPRX4MAPTRXRARXRB
SCHEMBL7368681 0.83 NPC1 (0.62) MRGPRX4KDM4ERXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143271-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2012-03-27 US disclosed
US-8143271-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2012-03-27 US disclosed